Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,058 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical Setting.
Stossel C, Raitses-Gurevich M, Atias D, Beller T, Glick Gorman Y, Halperin S, Peer E, Denroche RE, Zhang A, Notta F, Wilson JM, O'Kane GM, Haimov Talmoud E, Amison N, Schvimer M, Salpeter SJ, Bar V, Zundelevich A, Tirosh I, Tal R, Dinstag G, Kinar Y, Eliezer Y, Ben-David U, Gavert NS, Straussman R, Gallinger SJ, Berger R, Golan T. Stossel C, et al. Among authors: berger r. Cancer Discov. 2023 Aug 4;13(8):1826-1843. doi: 10.1158/2159-8290.CD-22-0412. Cancer Discov. 2023. PMID: 37449843 Free PMC article.
A clinical evaluation of an ex vivo organ culture system to predict patient response to cancer therapy.
Golan S, Bar V, Salpeter SJ, Neev G, Creiderman G, Kedar D, Aharon S, Turovsky L, Zundelevich A, Shahar H, Shapira H, Mallel G, Stossel E, Gavert N, Straussman R, Dotan Z, Berger R, Stossel C, Golan T, Halperin S, Leibovici D, Breuer S, Rottenberg Y, Applebaum L, Hubert A, Nechushtan H, Peretz T, Zick A, Chertin B, Koulikov D, Sonnenblick A, Rosenbaum E. Golan S, et al. Among authors: berger r. Front Med (Lausanne). 2023 Sep 28;10:1221484. doi: 10.3389/fmed.2023.1221484. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37840996 Free PMC article.
Modeling epithelial-mesenchymal transition in patient-derived breast cancer organoids.
Bar-Hai N, Ben-Yishay R, Arbili-Yarhi S, Herman N, Avidan-Noy V, Menes T, Mansour A, Awwad F, Balint-Lahat N, Goldinger G, Hout-Siloni G, Adileh M, Berger R, Ishay-Ronen D. Bar-Hai N, et al. Among authors: berger r. Front Oncol. 2024 Oct 14;14:1470379. doi: 10.3389/fonc.2024.1470379. eCollection 2024. Front Oncol. 2024. PMID: 39469640 Free PMC article.
Botanical Formula LCS101: A Multi-Targeted Approach to Cancer Care.
Maimon Y, Samuels N, Cohen Z, Berger R, Rosenthal DS. Maimon Y, et al. Among authors: berger r. Integr Cancer Ther. 2018 Dec;17(4):1020-1026. doi: 10.1177/1534735418801528. Epub 2018 Oct 10. Integr Cancer Ther. 2018. PMID: 30303021 Free PMC article.
Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy, and Recurrence in Breast Cancer.
Dadiani M, Bossel Ben-Moshe N, Paluch-Shimon S, Perry G, Balint N, Marin I, Pavlovski A, Morzaev D, Kahana-Edwin S, Yosepovich A, Gal-Yam EN, Berger R, Barshack I, Domany E, Kaufman B. Dadiani M, et al. Among authors: berger r. Clin Cancer Res. 2016 Jul 15;22(14):3651-62. doi: 10.1158/1078-0432.CCR-15-2313. Epub 2016 Mar 8. Clin Cancer Res. 2016. PMID: 26957561
Effect of the botanical compound LCS102 on innate immunity.
Cohen Z, Maimon Y, Berger R, Morag O, Golan T, Samuels N. Cohen Z, et al. Among authors: berger r. Biomed Rep. 2020 Sep;13(3):17. doi: 10.3892/br.2020.1323. Epub 2020 Jul 2. Biomed Rep. 2020. PMID: 32765856 Free PMC article.
Ocular side effects of novel anti-cancer biological therapies.
Vishnevskia-Dai V, Rozner L, Berger R, Jaron Z, Elyashiv S, Markel G, Zloto O. Vishnevskia-Dai V, et al. Among authors: berger r. Sci Rep. 2021 Jan 12;11(1):787. doi: 10.1038/s41598-020-80898-7. Sci Rep. 2021. PMID: 33436995 Free PMC article.
4,058 results